Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Genetically Modified Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Transgenic Animal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Genetically Modified Drug include LFB Biotechnologies SA, Pharming Group NV, Pfizer, Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Amgen and F. Hoffmann-La Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Drugs made by genetically modified means are also called "biological drugs"
This report aims to provide a comprehensive presentation of the global market for Genetically Modified Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genetically Modified Drug. This report contains market size and forecasts of Genetically Modified Drug in global, including the following market information:
Global Genetically Modified Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Genetically Modified Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Genetically Modified Drug companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genetically Modified Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genetically Modified Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Genetically Modified Drug Market Segment Percentages, by Type, 2022 (%)
Transgenic Animal
Transgenic Plant
Global Genetically Modified Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Genetically Modified Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Genetically Modified Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Genetically Modified Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genetically Modified Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Genetically Modified Drug revenues share in global market, 2022 (%)
Key companies Genetically Modified Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Genetically Modified Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
LFB Biotechnologies SA
Pharming Group NV
Pfizer
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Amgen
F. Hoffmann-La Roche
Sanofi
Novartis
Eli Lilly
Takeda
Baxter
GlaxoSmithKline
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genetically Modified Drug, market overview.
Chapter 2: Global Genetically Modified Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Genetically Modified Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genetically Modified Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Genetically Modified Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Genetically Modified Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genetically Modified Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genetically Modified Drug Overall Market Size
2.1 Global Genetically Modified Drug Market Size: 2022 VS 2029
2.2 Global Genetically Modified Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Genetically Modified Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Genetically Modified Drug Players in Global Market
3.2 Top Global Genetically Modified Drug Companies Ranked by Revenue
3.3 Global Genetically Modified Drug Revenue by Companies
3.4 Global Genetically Modified Drug Sales by Companies
3.5 Global Genetically Modified Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Genetically Modified Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Genetically Modified Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Genetically Modified Drug Players in Global Market
3.8.1 List of Global Tier 1 Genetically Modified Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Genetically Modified Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Genetically Modified Drug Market Size Markets, 2022 & 2029
4.1.2 Transgenic Animal
4.1.3 Transgenic Plant
4.2 By Type - Global Genetically Modified Drug Revenue & Forecasts
4.2.1 By Type - Global Genetically Modified Drug Revenue, 2018-2023
4.2.2 By Type - Global Genetically Modified Drug Revenue, 2024-2029
4.2.3 By Type - Global Genetically Modified Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Genetically Modified Drug Sales & Forecasts
4.3.1 By Type - Global Genetically Modified Drug Sales, 2018-2023
4.3.2 By Type - Global Genetically Modified Drug Sales, 2024-2029
4.3.3 By Type - Global Genetically Modified Drug Sales Market Share, 2018-2029
4.4 By Type - Global Genetically Modified Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Genetically Modified Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Genetically Modified Drug Revenue & Forecasts
5.2.1 By Application - Global Genetically Modified Drug Revenue, 2018-2023
5.2.2 By Application - Global Genetically Modified Drug Revenue, 2024-2029
5.2.3 By Application - Global Genetically Modified Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Genetically Modified Drug Sales & Forecasts
5.3.1 By Application - Global Genetically Modified Drug Sales, 2018-2023
5.3.2 By Application - Global Genetically Modified Drug Sales, 2024-2029
5.3.3 By Application - Global Genetically Modified Drug Sales Market Share, 2018-2029
5.4 By Application - Global Genetically Modified Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Genetically Modified Drug Market Size, 2022 & 2029
6.2 By Region - Global Genetically Modified Drug Revenue & Forecasts
6.2.1 By Region - Global Genetically Modified Drug Revenue, 2018-2023
6.2.2 By Region - Global Genetically Modified Drug Revenue, 2024-2029
6.2.3 By Region - Global Genetically Modified Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Genetically Modified Drug Sales & Forecasts
6.3.1 By Region - Global Genetically Modified Drug Sales, 2018-2023
6.3.2 By Region - Global Genetically Modified Drug Sales, 2024-2029
6.3.3 By Region - Global Genetically Modified Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Genetically Modified Drug Revenue, 2018-2029
6.4.2 By Country - North America Genetically Modified Drug Sales, 2018-2029
6.4.3 US Genetically Modified Drug Market Size, 2018-2029
6.4.4 Canada Genetically Modified Drug Market Size, 2018-2029
6.4.5 Mexico Genetically Modified Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Genetically Modified Drug Revenue, 2018-2029
6.5.2 By Country - Europe Genetically Modified Drug Sales, 2018-2029
6.5.3 Germany Genetically Modified Drug Market Size, 2018-2029
6.5.4 France Genetically Modified Drug Market Size, 2018-2029
6.5.5 U.K. Genetically Modified Drug Market Size, 2018-2029
6.5.6 Italy Genetically Modified Drug Market Size, 2018-2029
6.5.7 Russia Genetically Modified Drug Market Size, 2018-2029
6.5.8 Nordic Countries Genetically Modified Drug Market Size, 2018-2029
6.5.9 Benelux Genetically Modified Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Genetically Modified Drug Revenue, 2018-2029
6.6.2 By Region - Asia Genetically Modified Drug Sales, 2018-2029
6.6.3 China Genetically Modified Drug Market Size, 2018-2029
6.6.4 Japan Genetically Modified Drug Market Size, 2018-2029
6.6.5 South Korea Genetically Modified Drug Market Size, 2018-2029
6.6.6 Southeast Asia Genetically Modified Drug Market Size, 2018-2029
6.6.7 India Genetically Modified Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Genetically Modified Drug Revenue, 2018-2029
6.7.2 By Country - South America Genetically Modified Drug Sales, 2018-2029
6.7.3 Brazil Genetically Modified Drug Market Size, 2018-2029
6.7.4 Argentina Genetically Modified Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Genetically Modified Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Genetically Modified Drug Sales, 2018-2029
6.8.3 Turkey Genetically Modified Drug Market Size, 2018-2029
6.8.4 Israel Genetically Modified Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Genetically Modified Drug Market Size, 2018-2029
6.8.6 UAE Genetically Modified Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 LFB Biotechnologies SA
7.1.1 LFB Biotechnologies SA Company Summary
7.1.2 LFB Biotechnologies SA Business Overview
7.1.3 LFB Biotechnologies SA Genetically Modified Drug Major Product Offerings
7.1.4 LFB Biotechnologies SA Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.1.5 LFB Biotechnologies SA Key News & Latest Developments
7.2 Pharming Group NV
7.2.1 Pharming Group NV Company Summary
7.2.2 Pharming Group NV Business Overview
7.2.3 Pharming Group NV Genetically Modified Drug Major Product Offerings
7.2.4 Pharming Group NV Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.2.5 Pharming Group NV Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Genetically Modified Drug Major Product Offerings
7.3.4 Pfizer Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Genetically Modified Drug Major Product Offerings
7.4.4 Roche Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories Genetically Modified Drug Major Product Offerings
7.5.4 Abbott Laboratories Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.5.5 Abbott Laboratories Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Genetically Modified Drug Major Product Offerings
7.6.4 Johnson & Johnson Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Merck & Co.
7.7.1 Merck & Co. Company Summary
7.7.2 Merck & Co. Business Overview
7.7.3 Merck & Co. Genetically Modified Drug Major Product Offerings
7.7.4 Merck & Co. Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.7.5 Merck & Co. Key News & Latest Developments
7.8 Amgen
7.8.1 Amgen Company Summary
7.8.2 Amgen Business Overview
7.8.3 Amgen Genetically Modified Drug Major Product Offerings
7.8.4 Amgen Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.8.5 Amgen Key News & Latest Developments
7.9 F. Hoffmann-La Roche
7.9.1 F. Hoffmann-La Roche Company Summary
7.9.2 F. Hoffmann-La Roche Business Overview
7.9.3 F. Hoffmann-La Roche Genetically Modified Drug Major Product Offerings
7.9.4 F. Hoffmann-La Roche Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.9.5 F. Hoffmann-La Roche Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Genetically Modified Drug Major Product Offerings
7.10.4 Sanofi Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Novartis
7.11.1 Novartis Company Summary
7.11.2 Novartis Genetically Modified Drug Business Overview
7.11.3 Novartis Genetically Modified Drug Major Product Offerings
7.11.4 Novartis Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.11.5 Novartis Key News & Latest Developments
7.12 Eli Lilly
7.12.1 Eli Lilly Company Summary
7.12.2 Eli Lilly Genetically Modified Drug Business Overview
7.12.3 Eli Lilly Genetically Modified Drug Major Product Offerings
7.12.4 Eli Lilly Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.12.5 Eli Lilly Key News & Latest Developments
7.13 Takeda
7.13.1 Takeda Company Summary
7.13.2 Takeda Genetically Modified Drug Business Overview
7.13.3 Takeda Genetically Modified Drug Major Product Offerings
7.13.4 Takeda Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.13.5 Takeda Key News & Latest Developments
7.14 Baxter
7.14.1 Baxter Company Summary
7.14.2 Baxter Business Overview
7.14.3 Baxter Genetically Modified Drug Major Product Offerings
7.14.4 Baxter Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.14.5 Baxter Key News & Latest Developments
7.15 GlaxoSmithKline
7.15.1 GlaxoSmithKline Company Summary
7.15.2 GlaxoSmithKline Business Overview
7.15.3 GlaxoSmithKline Genetically Modified Drug Major Product Offerings
7.15.4 GlaxoSmithKline Genetically Modified Drug Sales and Revenue in Global (2018-2023)
7.15.5 GlaxoSmithKline Key News & Latest Developments
8 Global Genetically Modified Drug Production Capacity, Analysis
8.1 Global Genetically Modified Drug Production Capacity, 2018-2029
8.2 Genetically Modified Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Genetically Modified Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Genetically Modified Drug Supply Chain Analysis
10.1 Genetically Modified Drug Industry Value Chain
10.2 Genetically Modified Drug Upstream Market
10.3 Genetically Modified Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Genetically Modified Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
